GlassScriptPhysician profile
Syed T Shahab
NPI 1457345951
$1,464.51
in general payments reported to CMS, 2019-2025
23 companies · $61.05 in 2025
The $61.05 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $592 · 2020: $81.21 · 2021: $49.49 · 2022: $234 · 2023: $264 · 2024: $183 · 2025: $61.05.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $508.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $508.32 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $217.05 | 2019-2023 | Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Terumo Medical Corporation | $170.22 | 2019-2023 | Azur Cx Detachable, Navicross |
| Boston Scientific Corporation | $138.56 | 2019-2024 | Lux-Dx Insertable Cardiac Monitor |
| Abbott Laboratories | $136.23 | 2022 | |
| Philips North America LLC | $109.63 | 2019-2023 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $95.67 | 2019-2024 | Jardiance |
| Merck Sharp & Dohme LLC | $81.83 | 2022-2024 | Verquvo |
| Janssen Pharmaceuticals, INC | $73.76 | 2019-2024 | Xarelto |
| Astellas Pharma US INC | $67.97 | 2019-2021 | |
| Kowa Pharmaceuticals America, INC. | $61.12 | 2019 | |
| Amgen INC. | $50.30 | 2021-2024 | Repatha |
| Cardiovascular Systems INC. | $39.25 | 2019-2022 | |
| Lilly USA, LLC | $35.97 | 2025 | Mounjaro, Zepbound |
| Actelion Pharmaceuticals US, INC. | $31.23 | 2024 | Opsumit |
| Inspire Medical Systems, INC. | $25.08 | 2025 | Inspire |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exact Sciences Corporation | $21.95 | 2024 | Cologuard Collection Kit |
| Arbor Pharmaceuticals, INC. | $18.26 | 2019 | |
| Bardy Diagnostics, INC. | $16.75 | 2020 | |
| Cook Medical LLC | $16.61 | 2020 | |
| W. L. Gore & Associates, INC. | $16.17 | 2019 | |
| Silk Road Medical, INC. | $14.55 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $13.67 | 2019 | |
| Medtronic Vascular, INC. | $12.68 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Syed Shahab listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.